MLTX
Price
$46.88
Change
-$1.95 (-3.99%)
Updated
Jun 6 closing price
Capitalization
2.98B
61 days until earnings call
XENE
Price
$31.64
Change
+$0.91 (+2.96%)
Updated
Jun 6 closing price
Capitalization
2.43B
61 days until earnings call
Interact to see
Advertisement

MLTX vs XENE

Header iconMLTX vs XENE Comparison
Open Charts MLTX vs XENEBanner chart's image
MoonLake Immunotherapeutics
Price$46.88
Change-$1.95 (-3.99%)
Volume$881.42K
Capitalization2.98B
Xenon Pharmaceuticals
Price$31.64
Change+$0.91 (+2.96%)
Volume$576.17K
Capitalization2.43B
MLTX vs XENE Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. XENE commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and XENE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (MLTX: $46.88 vs. XENE: $31.64)
Brand notoriety: MLTX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 164% vs. XENE: 49%
Market capitalization -- MLTX: $2.98B vs. XENE: $2.43B
MLTX [@Biotechnology] is valued at $2.98B. XENE’s [@Biotechnology] market capitalization is $2.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 6 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 6 bullish, 4 bearish.
  • XENE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than XENE.

Price Growth

MLTX (@Biotechnology) experienced а +20.17% price change this week, while XENE (@Biotechnology) price change was +9.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 07, 2025.

XENE is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.98B) has a higher market cap than XENE($2.43B). MLTX YTD gains are higher at: -13.426 vs. XENE (-19.286). MLTX has higher annual earnings (EBITDA): -141.71M vs. XENE (-276.74M). XENE has more cash in the bank: 627M vs. MLTX (448M). MLTX has less debt than XENE: MLTX (2.83M) vs XENE (9.02M). MLTX (0) and XENE (0) have equivalent revenues.
MLTXXENEMLTX / XENE
Capitalization2.98B2.43B123%
EBITDA-141.71M-276.74M51%
Gain YTD-13.426-19.28670%
P/E RatioN/AN/A-
Revenue00-
Total Cash448M627M71%
Total Debt2.83M9.02M31%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
60
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXXENE
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 10 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCEYX21.060.17
+0.81%
Macquarie Core Equity Fund Class Y
CWGIX69.100.25
+0.36%
American Funds Capital World Gr&Inc A
BRXAX15.43N/A
N/A
MFS Blended Research Intl Eq A
HIAHX15.44N/A
N/A
Hartford Healthcare HLS IA
INDIX17.92N/A
N/A
ALPS/Kotak India ESG I

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-3.99%
XENE - MLTX
46%
Loosely correlated
+2.96%
XNCR - MLTX
44%
Loosely correlated
+5.81%
IDYA - MLTX
44%
Loosely correlated
+2.99%
DNLI - MLTX
43%
Loosely correlated
+3.38%
CLDX - MLTX
42%
Loosely correlated
+9.32%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with IDYA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
+2.96%
IDYA - XENE
55%
Loosely correlated
+2.99%
ATXS - XENE
54%
Loosely correlated
+14.75%
CRNX - XENE
54%
Loosely correlated
+2.13%
KYMR - XENE
49%
Loosely correlated
-0.08%
RVMD - XENE
48%
Loosely correlated
+2.21%
More